Morphine hydrochloride 10mg/ml - 20mg/ml Injectable Ampoule

Morphine hydrochloride (Injectable Ampoule)




Volume Dosage 
 1ml 10mg
 1ml 20mg
 5ml 50mg
 5ml 100mg



Clinical Pharmacology
Opioid Analgesic (N: central nervous system)


Action on central nervous system :
Morphine has a dose-dependent analgesic action. It may act on psychomotor behavior and cause, depending on the dose and background, either sedation or agitation.


On respiratory centers and that of cough, morphine exerts from the onset of therapeutic doses, a depressive action. The depressor respiratory effects of morphine subside in chronic treatment. Action of morphine on the vomiting center, (via the chemoreceptor trigger zone (CTZ), particularly through stimulation by pain and cochleo-vestibular space), and on gastric emptying endows it with variable emetic properties.


Finally morphine results in myosis from central nervous system.


Action on the smooth muscle :
Morphine decreases tonicity and peristalsis of longitudinal fibres while increasing tonicity of circular fibres, causing spasm on sphincters (pylorus, ileum-caecal valvula, anal sphincter, sphincter of Oddi, vesical sphincter).


Resorption :

  • Since it is more quickly resorbed in blood by epidural route (via large venous plexus) than by intrathecal route (via small medullary capillaries), morphine-induced analgesia has a sustainedrelease action by intrathecal route.
  • By epidural and intrathecal route, supraspinal distribution is delayed.


Biodisponibility of oral administration compared to those administered by subcutaneous route is 50 %. Biodisponibility of oral administration compared to that administered by intravenous route accounts for 30 %.


Distribution :
After resorption, the binding of morphine to plasma proteins accounts for 30 %. Morphine crosses the hemato-encephalic barrier and placenta.


Metabolism :
Morphine is highly metabolized in glucuronoconjugated derivatives which go through an enterohepatic cycle. 6-glucuronide and normorphine are two active metabolites of the substance-mother.


Elimination :

  • Plasma half-life of morphine varies (from 2 to 6 hours).
  • Elimination of glucuronoconjugated derivatives is primarily through urine, both by glomerular filtration and tubular secretion.
  • Elimination in the feces is low (<10 %).


Therapeutic Indications of morphine hydrochloride 
Intense and/or resistant pain to analgesic of low level.


Download documents


Contacts to get additional informations on the product

Atropine Sulfate 0,25mg/ml - 0,50mg/ml - 1mg/ml Injectable Ampoule Calcium gluconate 10% Injectable Ampoule Furosemide 20mg/2ml Injectable Ampoule Glucose 5% - 10% - 30% Injectable Ampoule Magnesium chloride 10% (0,1g/ml) Injectable Ampoule Magnesium sulfate 15% (0,15 g/ml) Injectable Ampoule Morphine hydrochloride 10mg/ml - 20mg/ml Injectable Ampoule Morphine sulfate 1mg/ml - 50mg/ml Injectable Ampoule Potassium chloride 7,46% - 10% - 15% - 20% Injectable Ampoule Procaine hydrochloride 1% - 2% Injectable Ampoule Sodium Bicarbonate 1.4 % Injectable Ampoule Sodium Chloride 0.9% - 10% - 20% Injectable Ampoule Vitamin B12 1.000mcg Injectable Ampoule Water for injectable preparations Ampoule Potassium Chloride 10% Injectable Plastic Ampoule Sodium Chloride 0.9% Injectable Plastic Ampoule Water for injectable preparation Plastic Ampoule Dextrion G5 (G 5% - NaCl 0,2% - KCl 0,15% - Ca Gluconate 0,1%)/ Dextrion G10 ( G 10% - NaCl 0,2 % - KCl 0,15 % - Ca Gluconate 0,1 %) Injectable Vial Glucose 5% - 10% - 15% - 30% Injectable Vial Mannitol 20% Injectable Vial Metronidazole 500mg/100 ml Injectable Vial Ringer Injectable Vial Ringer Lactate Injectable Vial Sodium bicarbonate 1.4% Injectable Vial Sodium Chloride 0.9% Injectable Vial Saline Phenolated Injectable Vial Water for injectable preparations Vial Glucose 5% - 10% Injectable Bag Sodium Chloride 0.9% Injectable Bag Water for injectable preparations Plastic Vial Glucose 5% Injectable Plastic Vial Sodium chloride 0,9% Injectable Plastic Vial